Loading Page
Dr. Nobuko Hijiya, MD is a physician provider in New York, NY specializing in physician and pediatric hematology/oncology. She graduated from Niigata University School of Medicine. Dr. Nobuko Hijiya, MD is affiliated with NewYork-Presbyterian, ColumbiaDoctors and CUIMC/Herbert Irving Pavilion.
Dr. Nobuko Hijiya, MD graduated from Niigata University School of Medicine. She completed residency at NYU Langone Medical Center. She is certified by the Board Certification: pediatric hematology-oncology and has a state license in Illinois.
Medical School: Niigata University School of Medicine
Residency: NYU Langone Medical Center
Board Certification: Board Certification: pediatric hematology-oncology
Licensed In: Illinois
Dr. Nobuko Hijiya, MD appears to accept the following insurance providers: VNSNY CHOICE, CIGNA, Healthspring (Cigna Medicare), Local 1199, Empire Blue Cross/Blue Shield, Emblem/GHI, ElderServe, Medicare, Affinity Health Plan, Amida Care, UnitedHealthcare, Empire Blue Cross Blue Shield Healthplus, Emblem/Hip, Fidelis Care, MVP Health Care, WellCare, World Trade Center Health Plan, Magnacare (National), Multiplan, Healthfirst, MultiPlan, United Healthcare PPO, United Healthcare POS, United Healthcare HMO, Aetna POS, MVP Health Care, MagnaCare, Vytra, Great-West Healthcare, Healthfirst, Aetna EPO, Aetna PPO, Aetna HMO, GHI PPO, Group Health Incorporated (GHI), Aetna Signature Administrators, CIGNA PPO, CIGNA POS, CIGNA HMO, CIGNA EPO, EmblemHealth, WellCare, Medicaid Managed Care, Blue Shield PPO, Blue Shield HMO, Blue Shield EPO, HealthSpring, UnitedHealthcare, Affinity Health Plan, United Healthcare, Medicare, Medicaid, Railroad Medicare, Cigna, 1199SEIU, Oxford HMO, Fidelis Care, HIP PPO, HIP POS, HIP EPO, HIP HMO, Empire BlueCross BlueShield HMO, Empire BlueCross BlueShield PPO, Empire BlueCross BlueShield, Aetna, Healthfirst - Leaf (Exchange), ElderServe - Special Needs, AETNA - Student Health, MVP Health Care - Child/Family Health Plus, Healthfirst - Child/Family Health Plus, Empire Blue Cross - EPO, AETNA - NY Signature, Amida Care - Special Needs, AETNA - Medicare Managed Care, Healthfirst - Medicare Managed Care, VNSNY CHOICE - SelectHealth, VNSNY CHOICE - Medicare Managed Care, MVP Health Care - Essential Plan, World Trade Center Health Plan - World Trade Center Health Plan, Medicare - Traditional Medicare, VNSNY CHOICE - Special Needs and MVP Health Care - HMO.
According to our sources, Dr. Nobuko Hijiya, MD accepts the following insurance providers:
Dr. Nobuko Hijiya, MD does not have any reviews yet, be the first to leave a review of Dr. Nobuko Hijiya, MD here: Leave a Review
These charts describe general payments received by Dr. Nobuko Hijiya, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$7,501
KYMRIAH $5,957 |
ABL002 $1,395 |
TASIGNA $101 |
MIDOSTAURIN $48 |
|||
|
$5,387
Blincyto $4,536 |
Kyprolis $852 |
|||||
|
$4,216
BOSULIF $4,150 |
$66 |
|||||
|
$3,998
$3,998 |
||||||
|
$3,032
CLOLAR $2,990 |
$42 |
|||||
|
$8,670
SCEMBLIX $2,885 |
Oncaspar $2,772 |
BOSULIF $733 |
ASPARLAS $25 |
Erwinaze $22 |
Other $2,234 |
| $19,078 | |
| $4,540 | |
| $4,154 | |
| $2,960 | |
| $1,353 | |
| $720 |
Dr. Nobuko Hijiya, MD has received 158 research payments totaling $4,897,205.
My expertise is in pediatric hematology and oncology, with a particular focus on leukemias and lymphomas, or cancers of the blood, bone marrow, or lymph nodes. I am especially interested in chronic myeloid leukemia (CML). Because children are growing and developing, CML treatment and management present unique challenges—the same treatment options that work best for grown-ups may not be the right strategies for kids. I treat children, adolescents, and young adults. I love working with this population and developing long-lasting relationships with my young patients. I am especially passionate about delivering personalized care to each of them—because no two kids are the same. Diseases like leukemia and lymphoma are challenging for anyone, but they can be especially hard on children. Symptoms like fatigue and joint pain can make it hard to move, play, and act like a kid, and some treatments can have severe side effects. I work to manage children’s symptoms and choose the right treatments for their disease, based on their individual needs. Helping these children is the most satisfying goal I can imagine. My research revolves around the treatment of pediatric leukemias and lymphomas. I continue to explore the impact of current treatments, and I collaborate with basic science researchers to translate their breakthroughs into new drug development. I have also been involved in cancer survivorship research. As a professor and the section head of pediatric oncology, I am deeply committed to educating and mentoring medical students, residents, and fellows and helping to prepare the next generation of leaders in pediatric hematology/oncology.
